Other Viruses Citation List:
March 2 - March 15, 2012
Hepatitis B virus
1. Inhibition Effect Produced by Dominant Negative Mutant Fusion Protein PreS2-TLM-ScFv-HBcDN on HBV Replication in Vitro. Liu, W.X., H.H. Zhu, W. Wu, J.L. He, and Z. Chen, Journal of Viral Hepatitis, 2012. 19(4): p. 295-300; PMID[22404728].
[PubMed]. OV_0302-031512.
2. In Vitro Activity of Cepharanthine Hydrochloride against Clinical Wild-type and lamivudine-resistant Hepatitis B Virus Isolates. Zhou, Y., Y. Wang, Y. Zhang, L. Zheng, X. Yang, N. Wang, J. Jiang, F. Ma, D. Yin, C. Sun, and Q. Wang, European Journal of Pharmacology, 2012, [Epub ahead of print]; PMID[22387093].
[PubMed]. OV_0302-031512.
Hepatitis C Virus
3. Novel Human SR-BI Antibodies Prevent Infection and Dissemination of HCV in Vitro and in Humanized Mice. Lacek, K., K. Vercauteren, K. Grzyb, M. Naddeo, L. Verhoye, M.P. Slowikowski, S. Fafi-Kremer, A.H. Patel, T.F. Baumert, A. Folgori, G. Leroux-Roels, R. Cortese, P. Meuleman, and A. Nicosia, Journal of Hepatology, 2012, [Epub ahead of print]; PMID[22414763].
[PubMed]. OV_0302-031512.
4. Metabolism of Phosphatidylinositol 4-Kinase IIIalpha-dependent PI4P is Subverted by HCV and is Targeted by a 4-Anilino quinazoline with Antiviral Activity. Bianco, A., V. Reghellin, L. Donnici, S. Fenu, R. Alvarez, C. Baruffa, F. Peri, M. Pagani, S. Abrignani, P. Neddermann, and R. De Francesco, PLoS Pathogens, 2012. 8(3): p. e1002576; PMID[22412376].
[PubMed]. OV_0302-031512.
5. Optimization of Potent Hepatitis C Virus NS3 Helicase Inhibitors Isolated from the Yellow Dyes Thioflavine S and Primuline. Li, K., K.J. Frankowski, C.A. Belon, B. Neunswander, J. Ndjomou, A.M. Hanson, M.A. Shanahan, F.J. Schoenen, B.S. Blagg, J. Aube, and D.N. Frick, Journal of Medicinal Chemistry, 2012, [Epub ahead of print]; PMID[22409723].
[PubMed]. OV_0302-031512.
6. Inhibition of Hepatitis C Virus NS3 Helicase by Manoalide. Salam, K.A., A. Furuta, N. Noda, S. Tsuneda, Y. Sekiguchi, A. Yamashita, K. Moriishi, M. Nakakoshi, M. Tsubuki, H. Tani, J. Tanaka, and N. Akimitsu, Journal of Natural Products, 2012, [Epub ahead of print]; PMID[22394195].
[PubMed]. OV_0302-031512.
7. Let-7b is a Novel regulator of Hepatitis C Virus Replication. Cheng, J.C., Y.J. Yeh, C.P. Tseng, S.D. Hsu, Y.L. Chang, N. Sakamoto, and H.D. Huang, Cellular and Molecular Life Sciences : CMLS, 2012, [Epub ahead of print]; PMID[22391672].
[PubMed]. OV_0302-031512.
8. Integrated Structure-based Activity Prediction Model of Benzothiadiazines on Various Genotypes of HCV NS5B Polymerase (1a, 1b and 4) and Its Application in the Discovery of New Derivatives. Ismail, M.A., D.A. Abou El Ella, K.A. Abouzid, and A.H. Mahmoud, Bioorganic & Medicinal Chemistry, 2012. 20(7): p. 2455-2478; PMID[22386565].
[PubMed]. OV_0302-031512.
9. Discovery of N-Arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide Derivatives as HCV NS5B Polymerase Inhibitors. Deore, R.R., G.S. Chen, P.T. Chang, T.R. Chern, S.Y. Lai, M.H. Chuang, J.H. Lin, F.L. Kung, C.S. Chen, C.T. Chiou, and J.W. Chern, ChemMedChem, 2012, [Epub ahead of print]; PMID[22383290].
[PubMed]. OV_0302-031512.
10. A Human Claudin-1 Derived Peptide Inhibits Hepatitis C Virus Entry. Si, Y., S. Liu, X. Liu, J.L. Jacobs, M. Cheng, Y. Niu, Q. Jin, T. Wang, and W. Yang, Hepatology (Baltimore, Md.), 2012, [Epub ahead of print]; PMID[22378192].
[PubMed]. OV_0302-031512.
HSV-1
11. Bilirubin: An Endogenous Molecule with Antiviral Activity in Vitro. Santangelo, R., C. Mancuso, S. Marchetti, E. Di Stasio, G. Pani, and G. Fadda, Frontiers in pharmacology, 2012. 3: p. 36; PMID[22408623].
[PubMed]. OV_0302-031512.
Citations from the ISI Web of Knowledge Listings for O.V.
12. Stereoselective Synthesis and anti-HCV Activity of Conformationally Restricted 2 '-C-Substituted carbanucleosides. Choi, W.J., Y.J. Ko, G. Chandra, H.W. Lee, H.O. Kim, H.J. Koh, H.R. Moon, Y.H. Jung, and L.S. Jeong, Tetrahedron, 2012. 68(4): p. 1253-1261; ISI[000300028800038].
[WOS]. OV_0302-031512.
13. 2-Hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid with Inbuilt beta-N-Hydroxy-gamma-keto-acid Pharmacophore as HCV NS5B Polymerase Inhibitors. Deore, R.R., G.S. Chen, C.S. Chen, P.T. Chang, M.H. Chuang, T.R. Chern, H.C. Wang, and J.W. Chern, Current medicinal chemistry, 2012. 19(4): p. 613-624; ISI[000300410700009].
[WOS]. OV_0302-031512.
14. Synthesis of Novel Azanorbornylpurine Derivatives. Hrebabecky, H., M. Dejmek, M. Dracinsky, M. Sala, P. Leyssen, J. Neyts, M. Kaniakova, J. Krusek, and R. Nencka, Tetrahedron, 2012. 68(4): p. 1286-1298; ISI[000300028800043].
[WOS]. OV_0302-031512.
15. Synthesis of Novel Anthracene Derivatives of Isoxazolino-carbocyclic nucleoside Analogues. Moggio, Y., L. Legnani, B. Bovio, M.G. Memeo, and P. Quadrelli, Tetrahedron, 2012. 68(5): p. 1384-1392; ISI[000299759000007].
[WOS]. OV_0302-031512.
16. Identification of the Niemann-Pick C1-like 1 Cholesterol Absorption Receptor as a New Hepatitis C Virus Entry Factor. Sainz, B., N. Barretto, D.N. Martin, N. Hiraga, M. Imamura, S. Hussain, K.A. Marsh, X.M. Yu, K. Chayama, W.A. Alrefai, and S.L. Uprichard, Nature Medicine, 2012. 18(2): p. 281-285; ISI[000300140300043].
[WOS]. OV_0302-031512.